Influence of the number of high-risk cytogenetic abnormalities on the clinical characteristics and prognosis in 360 patients with newly diagnosed multiple myeloma

被引：0
|
作者：
陈智 [1 ]
机构：
[1] Dept Hematol,1st Affil Hosp,Nanjing Med Univ
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2022年 / 39卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R733.3 [骨髓肿瘤];
学科分类号：
摘要：
Objective To investigate the influence of the number of high-risk cytogenetic abnormalities (HRCA)on the clinical characteristics and prognosis of patients with newly diagnosed multiple myeloma (MM).Methods A total of 360 patients with newly diagnosed MM admitted to Jiangsu Province Hospital between November 2013 and September 2020 were included in this study. Cytoplasmic light chain immunofluorescence with fluorescence in situ hybridization (cIg-FISH) was used to detect HRCA. Cytogenetic abnormalities were combined with clinical characteristics and outcomes for further analysis. Results Among the 360 patients,120patients (33.3%) didn’t present with HRCAs,and 175(48.6%),61 (16.9%),and four (1.1%) patients had one, two, and three HRCA (s), respectively.
引用
收藏
页码：182 / 183
页数：2
相关论文
共 50 条
  • [31] Myeloma: management of the newly diagnosed high-risk patient
    Dispenzieri, Angela
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 485 - 494
  • [32] Survival in Patients with Newly Diagnosed Myeloma Undergoing Therapy with Lenalidomide and Dexamethasone: Impact of High-Risk Cytogenetic Risk Status on Outcome
    Kapoor, Prasnant
    Kumar, Shaji
    Fonseca, Rafael
    Lacy, Martha Q.
    Wilzig, Thomas E.
    Hayman, Suzanne R.
    Dispenzieri, Angela
    Buadi, Francis
    Bergsagel, P. Leif
    Gertz, Morie
    Dalton, Robert
    Mikhael, Joseph
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russell, Stephen
    Roy, Vivek
    Zeldenrust, Steven R.
    Stewart, Keith
    Kyle, Robert A.
    Greipp, Philip R.
    Rajkumar, S. Vincent
    BLOOD, 2008, 112 (11) : 42 - 43
  • [33] Rare Igh Translocations in Newly Diagnosed Multiple Myeloma (MM) Patients: Cytogenetic Characterization and Relevance on Prognosis
    Marzocchi, Giulia
    Ameli, Gaia
    Pezzi, Annalisa
    Zamagni, Elena
    Cavallo, Federica
    Petrucci, Maria Teresa
    Waage, Anders
    Di Raimondo, Francesco
    Patriarca, Francesca
    Rambaldi, Alessandro
    Gamberi, Barbara
    Crippa, Claudia
    Zweegman, Sonja
    Montefusco, Vittorio
    Vincelli, Iolanda
    Offidani, Massimo
    Palumbo, Antonio
    Sonneveld, Pieter
    Cavo, Michele
    Testoni, Nicoletta
    BLOOD, 2014, 124 (21)
  • [34] Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma
    Caro, Jessica
    Cairns, David
    Menzies, Tom
    Boyle, Eileen
    Pawlyn, Charlotte
    Cook, Gordon
    Kaiser, Martin
    Walker, Brian A.
    Owen, Roger
    Jackson, Graham H.
    Morgan, Gareth J.
    Heaney, Jennifer
    Drayson, Mark
    Davies, Faith E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (04): : E279 - E284
  • [35] Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
    Merz, Maximilian
    Jauch, Anna
    Hielscher, Thomas
    Bochtler, Tilmann
    Schoenland, Stefan Olaf
    Seckinger, Anja
    Hose, Dirk
    Bertsch, Uta
    Neben, Kai
    Raab, Marc Steffen
    Hillengass, Jens
    Salwender, Hans
    Blau, Igor Wolfgang
    Lindemann, Hans-Walter
    Schmidt-Wolf, Ingo G. H.
    Scheid, Christof
    Haenel, Mathias
    Weisel, Katja C.
    Goldschmidt, Hartmut
    BLOOD ADVANCES, 2018, 2 (01) : 1 - 9
  • [36] Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients
    Charalampous, Charalampos
    Goel, Utkarsh
    Kapoor, Prashant
    Binder, Moritz
    Buadi, Francis
    Dingli, David
    Dispenzieri, Angela
    Fonder, Amie
    Gertz, Morie
    Gonsalves, Wilson
    Hayman, Suzanne
    Hobbs, Miriam
    Hwa, Yi Lisa
    Kourelis, Taxiarchis
    Lacy, Martha
    Leung, Nelson
    Lin, Yi
    Warsame, Rahma
    Kyle, Robert
    Rajkumar, Vincent
    Kumar, Shaji
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S149 - S150
  • [37] Risk Factors and Prognosis of Extramedullary Disease in Newly-Diagnosed Multiple Myeloma Patients
    Gunes, Ebru Kilic
    Bulduk, Tuba
    Dumludag, Burak
    Zengin, Haydar
    Yildirim, Murat
    Comert, Melda
    Ayli, Meltem
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S167 - S168
  • [38] Outcomes of Patients By High-Risk Cytogenetic Abnormalities in a Phase II Study of Isatuximab, Weekly Carfilzomib, Lenalidomide, Dexamethasone in Newly Diagnosed, Multiple Myeloma (The SKylaRk Trial) Who Deferred Transplant
    O'Donnell, Elizabeth K.
    Mo, Clifton C.
    Nadeem, Omar
    Laubach, Jacob
    Rosenblatt, Jacalyn
    Munshi, Nikhil C.
    Midha, Shonali
    Cirstea, Diana
    Richardson, Paul G.
    Raje, Noopur
    Yee, Andrew J.
    BLOOD, 2024, 144 : 4747 - 4748
  • [39] Risk Factors and Prognosis of Extramedullary Disease in Newly-Diagnosed Multiple Myeloma Patients
    Gunes, Ebru K. I. L. I. C.
    Bulduk, Tuba
    Dumludag, Burak
    Zengin, Haydar
    Yildirim, Murat
    Comert, Melda
    Ayli, Meltem
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (04): : 175 - 183
  • [40] Medullary Abnormalities in Appendicular Skeletons Detected With 18F-FDG PET/CT Predict an Unfavorable Prognosis in Newly Diagnosed Multiple Myeloma Patients With High-Risk Factors
    Abe, Yoshiaki
    Narita, Kentaro
    Kobayashi, Hiroki
    Kitadate, Akihiro
    Takeuchi, Masami
    O'uchi, Toshihiro
    Matsue, Kosei
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (04) : 918 - 924
12345